Sleep Aids Market, By Product Type (Medication, Sleep laboratories, Mattresses and pillows, Sleep apnea devices, Others), By Sleep Disorder (Insomnia, Sleep apnea, Restless legs syndrome, Narcolepsy, Night terrors, Others), and by Region (North America, L

Sleep Aids Market, By Product Type (Medication, Sleep laboratories, Mattresses and pillows, Sleep apnea devices, Others), By Sleep Disorder (Insomnia, Sleep apnea, Restless legs syndrome, Narcolepsy, Night terrors, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Sleeping aids, also known as hypnotics are sleeping pills or devices, which are used to induce sleep. It is used in the treatment of various sleeping disorders such as narcolepsy, sleep apnea, and insomnia, which are caused due to factors such as psychiatric disorders (Depression and anxiety), environmental problems (light, noise and extreme temperatures) medical issues (asthma) and others. Sleeping aid medications include non-benzodiazepines, antidepressants, and antipsychotics for the treatment of sleeping disorders. However, various behavioral therapies such as light therapy, cognitive behavioral therapy, and relaxation techniques are also used in the treatment of these disorders. According to Centers for Disease Control and Prevention (CDC), in 2017, around 49.2 million people across the globe have trouble focusing due to lack of sleep.
Restraints of the Global Sleeping Aids Market
Major factors hampering the growth of the sleep aids market during the forecast period constitutes of side effects associated with sleep aid medications, and patent expirations of medications.
Key features of the study:
This report provides in-depth analysis of the global sleeping aids market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global sleeping aids market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Sanofi S.A., Merck & Co., Inc., Pfizer, Inc., Koninklijke Philips N.V., GlaxoSmithKline Plc, Sommetrics, Inc., ResMed Inc., Cadwell Laboratories, Inc., Therapix Biosciences Ltd., SleepMed, Inc., Natus Medical Incorporated, DeVilbiss Healthcare LLC, and Compumedics Limited.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global sleeping aids market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Sleeping Aids Market, By Product Type:
Medication
Sleep laboratories
Mattresses and pillows
Sleep apnea devices
Others
Global Sleeping Aids Market, By Sleep Disorder:
Insomnia
Sleep apnea
Restless legs syndrome
Narcolepsy
Night terrors
Others
Global Sleeping Aids Market, By Geography:
North America
By Product Type
Medication
Sleep laboratories
Mattresses and pillows
Sleep apnea devices
Others
By Sleep Disorder:
Insomnia
Sleep apnea
Restless legs syndrome
Narcolepsy
Night terrors
Others
By Country:
U.S.
Canada
Europe
By Product Type
Medication
Sleep laboratories
Mattresses and pillows
Sleep apnea devices
Others
By Sleep Disorder:
Insomnia
Sleep apnea
Restless legs syndrome
Narcolepsy
Night terrors
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type
Medication
Sleep laboratories
Mattresses and pillows
Sleep apnea devices
Others
By Sleep Disorder:
Insomnia
Sleep apnea
Restless legs syndrome
Narcolepsy
Night terrors
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type
Medication
Sleep laboratories
Mattresses and pillows
Sleep apnea devices
Others
By Sleep Disorder:
Insomnia
Sleep apnea
Restless legs syndrome
Narcolepsy
Night terrors
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Product Type
Medication
Sleep laboratories
Mattresses and pillows
Sleep apnea devices
Others
By Sleep Disorder:
Insomnia
Sleep apnea
Restless legs syndrome
Narcolepsy
Night terrors
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type
Medication
Sleep laboratories
Mattresses and pillows
Sleep apnea devices
Others
By Sleep Disorder:
Insomnia
Sleep apnea
Restless legs syndrome
Narcolepsy
Night terrors
Others
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Sanofi S.A.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Merck & Co., Inc.
Pfizer, Inc.
Koninklijke Philips N.V.
GlaxoSmithKline Plc
Sommetrics, Inc.
ResMed Inc.
Cadwell Laboratories, Inc.
Therapix Biosciences Ltd.
SleepMed, Inc.
Natus Medical Incorporated
DeVilbiss Healthcare LLC
Compumedics Limited
“*” marked represents similar segmentation in other categories in the respective section.